Correction to Lancet Infect Dis 2024; published online Oct 23. https://doi.org/10.1016/S1473-3099(24)00527-9

Macià D, Campo JJ, Jairoce C, et al. The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01_E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial. Lancet Infect Dis 2024; published online Oct 23. https://doi.org/10.1016/S1473-3099(24)00527-9—In the table of this Article, the † footnote has been removed from the Kintampo row of the Infant section. In figure 2, the correlation values in panel C have been coloured blue and purple to indicate the age group to which they are referring and the legend has been updated to state that, in panel B, “Green dots indicate significant results at a false discovery rate below 5%.” In panel A of figure 4, the text has been updated to refer to “High pre-vaccination Plasmodium falciparum IgG levels”. And in the Results section, the first sentence of the second paragraph has been corrected to “IgG levels to 981 (98%) out of 1000 P falciparum antigens showed a significant increase following a malaria episode”. These corrections have been made to the online version as of Jan 16, 2025, and will be made to the printed version.